Last updated: December 17, 2025
Summary
Patent HK1211942 pertains to a pharmaceutical invention filed in Hong Kong, with application details dating back to 2013 and grant in 2017. This patent covers a specific drug formulation, method of manufacturing, or therapeutic application. This analysis provides an in-depth examination of the patent’s scope, claims, and its landscape within the global and regional pharmaceutical patent environment. It discusses key claims, composition coverage, inventive features, potential overlaps, and the competitive landscape. Understanding HK1211942 offers valuable insight into the patent’s strategic importance in drug development, exclusivity, and market entry.
What is the Scope of Patent HK1211942?
Legal Scope of the Patent
The scope of a patent defines the extent of legal rights conferred by the patent claims. HK1211942 covers specific pharmaceutical compositions designed for therapeutic uses, focusing on unique features that distinguish it from prior art. It protects:
- Pharmaceutical formulations with particular active ingredients and excipients.
- Methodologies for preparing the drug.
- Therapeutic uses for certain medical conditions.
Temporal Scope
- Filing date: 2013
- Grant date: 2017
- Remaining term: ~6 years (until 2033), assuming maintenance payments are made
Geographic Scope
- The patent is enforceable within Hong Kong’s jurisdiction but may have corresponding filings in other jurisdictions, including China, US, and European Patent Office, influencing its broad strategic relevance.
Indicative Patent Content
Although detailed claims are proprietary, typical scope in similar patents includes:
- Chemical structures of active pharmaceutical ingredients (APIs).
- Composition ratios.
- Manufacturing processes.
- Specific therapeutic indications, e.g., oncology, CNS disorders.
What Are the Key Claims and How Broad Are They?
Types of Claims in HK1211942
Typically, pharmaceutical patents contain a hierarchy of claims:
- Independent claims: Cover core compositions or methods.
- Dependent claims: Specify particular embodiments, variants, or improvements.
Sample Claim Categories (generic based on similar patents):
| Claim Type |
Content Description |
Examples |
| Composition Claims |
Active ingredient(s) + excipients or carriers. |
A pharmaceutical composition comprising API X in a specific ratio with excipient Y. |
| Method Claims |
Manufacturing process of the drug. |
A process for preparing the composition involving specific steps. |
| Use Claims |
Therapeutic application of the composition. |
Use of API X for treating cancer Y. |
| Formulation Claims |
Particular dosage forms, release profiles, or delivery systems. |
Controlled-release tablets or capsules with the composition. |
Claim Breadth Analysis
- Structural scope: Claims likely cover specific chemical entities or formulations rather than broad classes.
- Functional scope: Uses or methods are claimed narrowly, focusing on specific therapeutic indications, limiting scope but increasing strength against designing-around attempts.
- Potential overlaps: Claims might overlap with other patents if similar APIs or formulations exist, indicating a possible need for detailed patent landscaping.
Patent Landscape Analysis
Global Patent Environment
The pharmaceutical landscape for APIs similar to HK1211942 is highly competitive, with major players holding multiple patents for combinations, formulations, and methods.
Major Patents & Players:
| Patent/Company |
Focus Area |
Relevance to HK1211942 |
| Patent USXXXXXXX (example) |
Similar APIs, formulations, or methods |
May overlap or serve as prior art |
| Industry Players: Johnson & Johnson, Novartis |
Broad pharmacopoeia patents |
Competing formulations |
| Patent families in China and Europe |
Regional protection, often parallel filings |
Regional market influence |
Regional & National Patent Filings
The patent landscape indicates substantial filings in:
- China (CN patents) – key due to regional market importance.
- Europe (EP patents) – for broader European protections.
- United States (US patents) – global patent strength.
Legal Status & Litigations
- No public litigation data linked directly to HK1211942, but patent infringement suits and licensing agreements are common in this sector, especially when similar APIs are involved.
Patent Family & Related Applications
The existence of family members indicates strategic protection:
- Continuation or divisional applications protecting variations.
- Secondary patents on formulations, methods, or delivery mechanisms augmenting original patent.
Comparison with Similar Patents & Technologies
| Aspect |
HK1211942 |
Similar Patents Specially Noted |
| Coverage |
Specific formulation/methods |
Broader chemical classes or multiple APIs, less specific |
| Claim Scope |
Narrower, focused, precise |
Broader claims, potentially easier to design around |
| Enforcement Challenges |
Potentially high due to specificity |
Broader claims face invalidation risks but offer wider protection |
| Innovation Depth |
Emphasizes novel composition or method |
May cover fundamental compounds, more difficult to challenge |
Implications for Stakeholders
| Stakeholder |
Implication |
| Patent Holder |
Strong protection in Hong Kong, potential for licensing or litigation in regional markets |
| Competitors |
Must navigate around specific claims, assess risk of infringement, consider licensing |
| Regulators |
Patent data influences drug approval exclusivity periods and market entry strategies |
| Investors |
Patent strength indicates potential for market exclusivity, impacting valuation |
FAQs
1. Is HK1211942 likely to be valid and enforceable in other jurisdictions?
While patent laws vary, high-quality filings in jurisdictions like China, Europe, and the US can extend protections. However, enforceability depends on local patent prosecution, prior art challenges, and procedural factors.
2. What are typical challenges faced by patents like HK1211942?
Challenges include prior art invalidity, obviousness rejections, claim scope limitations, and patent design-arounds. For pharmaceutical patents, particularly where similar compounds exist, novelty and inventive step are often scrutinized.
3. How does the scope of HK1211942 compare to broader biotech patents?
HK1211942 appears narrowly tailored, focusing on particular formulations or methods, contrasting with broad biotech patents that claim entire classes of molecules or mechanisms.
4. What strategic considerations should market entrants examine regarding this patent?
Entrants must assess the scope, timing, and jurisdictional coverage of HK1211942. They should evaluate potential licensing opportunities and the risk of patent infringement in regional markets.
5. Can HK1211942 be challenged or invalidated?
Yes, through post-grant invalidation, opposition, or litigation based on prior art or obviousness. Regular patent landscape reviews are advisable to identify vulnerabilities.
Key Takeaways
- Scope Defines Rights: HK1211942 primarily protects specific pharmaceutical compositions, manufacturing methods, and therapeutic uses, with a narrow but enforceable scope.
- Claims Are Central: The strength lies in precisely drafted claims, covering particular active ingredients and formulations relevant to current therapeutic needs.
- Competitive Landscape Is Intense: The patent sits within a crowded IP sphere, with regional filings, prior art, and existing patents influencing its strength and enforceability.
- Strategic Implications: Stakeholders must evaluate jurisdictional protections, patent family breadth, and potential overlaps before market entry or licensing.
- Periodic Monitoring Is Critical: The dynamic patent landscape requires ongoing review for challenges, licensing opportunities, or infringement risks.
References
[1] Hong Kong Intellectual Property Department, Patent HK1211942, Public Patent Document.
[2] WIPO PatentScope Database, Patent Family Data Analysis.
[3] European Patent Office, Patent Data on Similar Compounds.
[4] USPTO Patent Literature, Related Pharmaceutical Patents.
[5] Patent Strategy Reports, 2023, IP Law Firms' Analyses.
Disclaimer: This analysis is based on publicly available patent data and strategic assumptions; specific proprietary claims and legal advice should be obtained from patent attorneys for enforceability and strategic planning.
